Lutanen Participates in the Design of Harvard Medical School Longevity Symposium

Dr. Julia Loewenthal and I were invited to help design a longevity symposium within Internal Medicine: Innovations and New Practices 2026, a continuing medical education course hosted by Harvard Medical School and Brigham and Women’s Hospital. This represents an important opportunity to bring academic and scientific rigor to longevity education, an area that remains largely absent from formal internal medicine training, and to help lay the groundwork for our flagship Human Longevity Continuing Medical Education stand-alone course planned for 2026–2027, in partnership with Harvard Medical School.

“Longevity” has largely existed either in theoretical biomarker research or in commercial and marketing-driven narratives. What it has lacked is consistent clinical translation. Internal medicine, by definition, is longitudinal. It is the specialty that follows patients over decades, across life transitions, uncertainty, and the full spectrum of health and disease. It is also the specialty responsible for many of the most consequential diagnostic and therapeutic decisions in medicine. For these reasons, internal medicine provides the natural clinical scaffolding on which longevity and gerotherapeutic principles can rest.

With the rapid expansion of aging biology, precision risk stratification, and emerging strategies aimed at modifying fundamental aging pathways, the central challenge is now clinical integration. As technologies mature and the underlying science accelerates, clinicians need practical, grounded frameworks they can apply in day-to-day care. The goal is to translate longevity science into approaches that are both evidence-based and human-centered, and to move it from innovation into common clinical knowledge within internal medicine.

Patients are increasingly driving this shift as well. Many are less interested in reassurance alone and more interested in understanding their long-term trajectory and reducing future risk. They want insight into what their current physiology suggests about the coming decades, not simply whether today’s laboratory values fall within reference ranges. If internal medicine does not meet this demand with rigor and discernment, patients will continue to seek answers elsewhere, often from longevity influencers.

This evolution changes the nature of the clinical encounter itself. Visits become not only about ruling out disease or arriving at a diagnosis, but about building a durable physician–patient relationship focused on vitality, function, meaning, and healthy aging over time. Gerotherapeutic thinking shifts care toward preserving physiologic reserve, delaying functional decline, and intervening earlier in the disease process, well before irreversible pathology develops.

In practice, this means assessing strength, balance, and physical resilience with the same seriousness as blood pressure. Sleep and stress physiology are treated as clinically relevant data. Prevention becomes an ongoing, adaptive process rather than a one-time educational intervention. In this form, longevity is neither speculative nor performative. It is methodical, longitudinal, and firmly rooted in clinical medicine.

There is nothing especially glamorous about this version of longevity. But it is the version that is real, and the version physicians must be trained to practice.

Being asked to shape a longevity symposium within Innovations and New Practices 2026 feels like a homecoming. Longevity is not a new ambition for medicine. It is simply what internal medicine has always promised. That is the work Julia and I care deeply about, and it is where we believe we can help move the field.

About the Author:

Dr. Jay Luthar is a Harvard-trained internist and the founder of Lutanen Health, where he leads a longevity-focused model of primary care that blends advanced diagnostics, evidence-based medicine, and mind-body health. He is triple board certified in Internal, Integrative, and Lifestyle Medicine and teaches at Harvard Medical School. His work bridges modern clinical science with personalized, relationship-centered care.

Dr. Jay Luthar, MD, DipABLM

January 2, 2026